Is a complete BCBA/LLY research report available?

No complete published report is available for bcba/LLY (BCBA/LLY) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/LLY (BCBA/LLY)

Buenos Aires Stock Exchange: BCBA/LLY · ARS

ARS 38,200

+380.00 (+1.0%)· Recorded snapshot

Market cap	1765.5T
Revenue (ttm)	118T
Net income (ttm)	39.6T
EPS (ttm)	ARS 820
P/E (trailing)	46.6x
P/E (forward)	33.7x
Dividend	ARS 131 (0.34%)
Volume	10,053
Beta	0.45

Market data

Price

Recent price action with selectable time range.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-10-29
Employees	50,000
Employees change	3,000
Employees growth	6.38%
Enterprise value	ARS 1834.9T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1876
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	ARDEUT111192
Last earnings date	2026-10-29
Last refreshed	2026-10-29
Last stock split date	2024-01-24
Last stock split type	Forward
Market cap	ARS 1765.5T
Next earnings date	2026-10-29
Price	ARS 38,200.00
Price currency	ARS
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	bcba/LLY
Website	https://www.lilly.com

Metric

Value

Amount currency

ARS

Country

United States

Country code

Earnings date

2026-10-29

Employees

50,000

Employees change

3,000

Employees growth

6.38%

Enterprise value

ARS 1834.9T

Exchange

Buenos Aires Stock Exchange

Financial currency

USD

Financial report date

2026-09-30

First seen

2026-05-10

Fiscal year end

December

Founded

1876

Industry

Drug Manufacturers - General

Is primary listing

ISIN number

ARDEUT111192

Last earnings date

2026-10-29

Last refreshed

2026-10-29

Last stock split date

2024-01-24

Last stock split type

Forward

Market cap

ARS 1765.5T

Next earnings date

2026-10-29

Price

ARS 38,200.00

Price currency

ARS

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

bcba/LLY

Website

https://www.lilly.com

Metric	Value
Average P/E ratio (10Y)	52.78x
Average P/E ratio (3Y)	71.41x
Average P/E ratio (5Y)	62.99x
Earnings yield	2.15%
EV/Earnings	46.37x
EV/EBIT	30.13x
EV/EBITDA	28.47x
EV/FCF	68.09x
EV/Sales	14.98x
FCF / EV yield	1.47%
FCF yield	1.53%
Forward P/E	33.75x
Graham number	4574.1568
Graham upside	-88.03%
Lynch fair value	ARS 21,406.20
Lynch upside	-43.96%
P/(FCF - SBC) ratio	67.94x
P/(OCF - SBC) ratio	43.44x
P/B ratio	35.17x
P/E ratio	46.58x
P/FCF ratio	65.51x
P/OCF ratio	42.43x
P/S ratio	14.96x
Price / tangible book value	172.21x
Price/EBITDA ratio	28.57x

Metric

Value

Average P/E ratio (10Y)

52.78x

Average P/E ratio (3Y)

71.41x

Average P/E ratio (5Y)

62.99x

Earnings yield

2.15%

EV/Earnings

46.37x

EV/EBIT

30.13x

EV/EBITDA

28.47x

EV/FCF

68.09x

EV/Sales

14.98x

FCF / EV yield

1.47%

FCF yield

1.53%

Forward P/E

33.75x

Graham number

4574.1568

Graham upside

-88.03%

Lynch fair value

ARS 21,406.20

Lynch upside

-43.96%

P/(FCF - SBC) ratio

67.94x

P/(OCF - SBC) ratio

43.44x

P/B ratio

35.17x

P/E ratio

46.58x

P/FCF ratio

65.51x

P/OCF ratio

42.43x

P/S ratio

14.96x

Price / tangible book value

172.21x

Price/EBITDA ratio

28.57x

Metric	Value
EBIT margin	49.72%
EBITDA margin	52.35%
Effective tax rate	20.49%
FCF margin	21.94%
Gross margin	83.4%
Operating margin	49.72%
Pretax margin	42.17%
Profit margin	33.53%
Profit per employee	ARS 791.4M
Profitable quarters	11
Profitable years	8
Revenue per employee	ARS 2.4B
ROA	20.36%
ROA (5Y)	13.51%
ROCE	41.89%
ROE	102.29%
ROE (5Y)	74.21%
ROIC	42.24%
ROIC (5Y)	35.51%
SBC / revenue	0.81%
Tax / revenue	8.64%

Metric

Value

EBIT margin

49.72%

EBITDA margin

52.35%

Effective tax rate

20.49%

FCF margin

21.94%

Gross margin

83.4%

Operating margin

49.72%

Pretax margin

42.17%

Profit margin

33.53%

Profit per employee

ARS 791.4M

Profitable quarters

Profitable years

Revenue per employee

ARS 2.4B

ROA

20.36%

ROA (5Y)

13.51%

ROCE

41.89%

ROE

102.29%

ROE (5Y)

74.21%

ROIC

42.24%

ROIC (5Y)

35.51%

SBC / revenue

0.81%

Tax / revenue

8.64%

Metric	Value
EPS growth	94.8%
EPS growth (Q)	26.23%
EPS growth (QoQ)	-3.87%
EPS growth 10Y	29.08%
EPS growth 3Y	60.68%
EPS growth 5Y	34.97%
EPS growth quarters	11
EPS growth years	2
FCF growth	272.37%
FCF growth (Q)	458.06%
FCF growth (QoQ)	157.96%
FCF growth 3Y	69.77%
FCF growth 5Y	26.73%
Gross profit growth	50.96%
Gross profit growth (Q)	50.31%
Gross profit growth 3Y	42.51%
Gross profit growth 5Y	26.7%
Net income growth	93.56%
Net income growth (Q)	25.33%
Net income growth (QoQ)	-4.07%
Net income growth 3Y	60.19%
Net income growth 5Y	34.49%
Net income growth quarters	11
Net income growth years	2
OCF growth	156.73%
OCF growth (Q)	246.29%
OCF growth (QoQ)	100.45%
OCF growth 10Y	23.94%
OCF growth 3Y	65.09%
OCF growth 5Y	31.67%
Operating income growth	78.34%
Operating income growth (Q)	77.42%
Operating income growth 3Y	68.37%
Operating income growth 5Y	38.93%
Revenue growth	49.58%
Revenue growth (Q)	47.67%
Revenue growth (QoQ)	16.04%
Revenue growth 10Y	14.48%
Revenue growth 3Y	39.23%
Revenue growth 5Y	24.41%
Revenue growth quarters	13
Revenue growth years	8

Metric

Value

EPS growth

94.8%

EPS growth (Q)

26.23%

EPS growth (QoQ)

-3.87%

EPS growth 10Y

29.08%

EPS growth 3Y

60.68%

EPS growth 5Y

34.97%

EPS growth quarters

EPS growth years

FCF growth

272.37%

FCF growth (Q)

458.06%

FCF growth (QoQ)

157.96%

FCF growth 3Y

69.77%

FCF growth 5Y

26.73%

Gross profit growth

50.96%

Gross profit growth (Q)

50.31%

Gross profit growth 3Y

42.51%

Gross profit growth 5Y

26.7%

Net income growth

93.56%

Net income growth (Q)

25.33%

Net income growth (QoQ)

-4.07%

Net income growth 3Y

60.19%

Net income growth 5Y

34.49%

Net income growth quarters

Net income growth years

OCF growth

156.73%

OCF growth (Q)

246.29%

OCF growth (QoQ)

100.45%

OCF growth 10Y

23.94%

OCF growth 3Y

65.09%

OCF growth 5Y

31.67%

Operating income growth

78.34%

Operating income growth (Q)

77.42%

Operating income growth 3Y

68.37%

Operating income growth 5Y

38.93%

Revenue growth

49.58%

Revenue growth (Q)

47.67%

Revenue growth (QoQ)

16.04%

Revenue growth 10Y

14.48%

Revenue growth 3Y

39.23%

Revenue growth 5Y

24.41%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	ARS -14.7T
Depreciation and amortization	ARS 3.2T
EBIT	ARS 58.7T
EBITDA	ARS 61.8T
EPS	ARS 820.06
Financing cash flow	ARS 3.9T
Free cash flow	ARS 26.9T
Free cash flow minus SBC	ARS 26T
Gross profit	ARS 98.4T
Income taxes	ARS 10.2T
Investing cash flow	ARS -37.2T
Net borrowing	ARS 23.5T
Net cash flow	ARS 8.3T
Net income	ARS 39.6T
Operating cash flow minus SBC	ARS 40.6T
Operating income	ARS 58.7T
Revenue	ARS 118T
Stock-based compensation	ARS 961.5B

Metric

Value

Capital expenditures

ARS -14.7T

Depreciation and amortization

ARS 3.2T

EBIT

ARS 58.7T

EBITDA

ARS 61.8T

EPS

ARS 820.06

Financing cash flow

ARS 3.9T

Free cash flow

ARS 26.9T

Free cash flow minus SBC

ARS 26T

Gross profit

ARS 98.4T

Income taxes

ARS 10.2T

Investing cash flow

ARS -37.2T

Net borrowing

ARS 23.5T

Net cash flow

ARS 8.3T

Net income

ARS 39.6T

Operating cash flow minus SBC

ARS 40.6T

Operating income

ARS 58.7T

Revenue

ARS 118T

Stock-based compensation

ARS 961.5B

Metric	Value
Altman Z-Score	6.55
Book value per share	ARS 56,300.32
Debt / EBITDA	1.31
Debt / equity	1.62
Debt / FCF	3.02
Goodwill	ARS 13.6T
Interest coverage	215.26
Long-term assets	ARS 111.1T
Long-term liabilities	ARS 87T
Net cash (debt)	ARS -66.9T
Net cash / market cap	-3.79%
Net debt / EBITDA	1.08
Net debt / equity	1.33
Net debt / FCF	2.48
Piotroski F-Score	7
Property, plant and equipment	ARS 45.1T
Shareholders' equity	ARS 50.2T
Tangible book value	ARS 10.3T
Tangible book value per share	ARS 11,499.70
Total assets	ARS 210.8T
Total cash	ARS 13.3T
Total debt	ARS 81.3T
Total liabilities	ARS 160.6T
WACC	6.46%

Metric

Value

Altman Z-Score

6.55

Book value per share

ARS 56,300.32

Debt / EBITDA

1.31

Debt / equity

1.62

Debt / FCF

3.02

Goodwill

ARS 13.6T

Interest coverage

215.26

Long-term assets

ARS 111.1T

Long-term liabilities

ARS 87T

Net cash (debt)

ARS -66.9T

Net cash / market cap

-3.79%

Net debt / EBITDA

1.08

Net debt / equity

1.33

Net debt / FCF

2.48

Piotroski F-Score

Property, plant and equipment

ARS 45.1T

Shareholders' equity

ARS 50.2T

Tangible book value

ARS 10.3T

Tangible book value per share

ARS 11,499.70

Total assets

ARS 210.8T

Total cash

ARS 13.3T

Total debt

ARS 81.3T

Total liabilities

ARS 160.6T

WACC

6.46%

Metric	Value
Asset turnover	0.66
Current assets	ARS 99.7T
Current liabilities	ARS 73.6T
Current ratio	1.35
Inventory turnover	0.95
Net working capital	ARS 22.3T
Quick ratio	0.68
Working capital	ARS 25.1T
Working capital turnover	8,501.69

Metric

Value

Asset turnover

0.66

Current assets

ARS 99.7T

Current liabilities

ARS 73.6T

Current ratio

1.35

Inventory turnover

0.95

Net working capital

ARS 22.3T

Quick ratio

0.68

Working capital

ARS 25.1T

Working capital turnover

8,501.69

Metric	Value
Buyback yield / dilution	0.62%
Dividend growth	58.09%
Dividend growth (10Y)	82.13%
Dividend growth (3Y)	113.44%
Dividend growth (5Y)	105.87%
Dividend growth years	23
Dividend payment date	2026-12-10
Dividend payment years	27
Dividend payout frequency	Quarterly
Dividend per share	ARS 131.25
Dividend yield	0.34%
Ex-dividend date	2026-11-13
Last dividend	ARS 47.63
Payout ratio	21.66%
Shareholder yield	0.96%

Metric

Value

Buyback yield / dilution

0.62%

Dividend growth

58.09%

Dividend growth (10Y)

82.13%

Dividend growth (3Y)

113.44%

Dividend growth (5Y)

105.87%

Dividend growth years

Dividend payment date

2026-12-10

Dividend payment years

Dividend payout frequency

Quarterly

Dividend per share

ARS 131.25

Dividend yield

0.34%

Ex-dividend date

2026-11-13

Last dividend

ARS 47.63

Payout ratio

21.66%

Shareholder yield

0.96%

Metric	Value
150-day SMA	ARS 30,839.33
1D price change	1%
1M price change	10.26%
1M total return	10.26%
1W price change	1.94%
1W total return	1.94%
1Y price change	76.32%
1Y return CAGR	77.05%
1Y total return	76.98%
20-day SMA	ARS 35,499.00
200-day SMA	ARS 29,958.00
3M price change	10.71%
3M total return	10.81%
3Y price change	336.94%
3Y return CAGR	64.07%
3Y total return	341.77%
50-day SMA	ARS 34,299.60
50-day SMA vs 200-day SMA	50over200
52-week high	ARS 38,820.00
52-week high date	2026-10-22
52-week low	ARS 21,420.00
52-week low date	2025-10-29
5Y price change	4,088.93%
5Y return CAGR	111.88%
5Y total return	4,168.22%
6M price change	60.19%
6M total return	60.49%
All-time high	ARS 38,820.00
All-time high date	2026-10-22
All-time low	ARS 328.57
All-time low date	2020-11-03
Average true range (ATR)	ARS 1,131.78
Average volume	21.5K
Beta (5Y)	0.45
Change from 52-week high	-1.6%
Change from 52-week low	78.34%
Change from all-time high	-2.58%
Change from all-time low	11,410.45%
Change from open	1.49%
Day's gap	-0.48%
Dollar volume	ARS 384M
High price	ARS 38,460.00
Low price	ARS 37,220.00
Monthly RSI	75.95
Open price	ARS 37,640.00
Position in 52-week range	79.03%
Previous close	ARS 37,820.00
Price vs 150-day SMA	22.64%
Price vs 20-day SMA	6.54%
Price vs 200-day SMA	26.24%
Price vs 50-day SMA	10.26%
Relative volume	0.47
RSI	67.59
Sharpe ratio	1.54
Sharpe ratio (3Y)	1.31
Sharpe ratio (5Y)	1.76
Sortino ratio	2.67
Sortino ratio (3Y)	2.1
Sortino ratio (5Y)	2.87
Volume	10.1K
Weekly RSI	67.93
YTD price change	28.73%
YTD total return	29.1%

Metric

Value

150-day SMA

ARS 30,839.33

1D price change

1M price change

10.26%

1M total return

10.26%

1W price change

1.94%

1W total return

1.94%

1Y price change

76.32%

1Y return CAGR

77.05%

1Y total return

76.98%

20-day SMA

ARS 35,499.00

200-day SMA

ARS 29,958.00

3M price change

10.71%

3M total return

10.81%

3Y price change

336.94%

3Y return CAGR

64.07%

3Y total return

341.77%

50-day SMA

ARS 34,299.60

50-day SMA vs 200-day SMA

50over200

52-week high

ARS 38,820.00

52-week high date

2026-10-22

52-week low

ARS 21,420.00

52-week low date

2025-10-29

5Y price change

4,088.93%

5Y return CAGR

111.88%

5Y total return

4,168.22%

6M price change

60.19%

6M total return

60.49%

All-time high

ARS 38,820.00

All-time high date

2026-10-22

All-time low

ARS 328.57

All-time low date

2020-11-03

Average true range (ATR)

ARS 1,131.78

Average volume

21.5K

Beta (5Y)

0.45

Change from 52-week high

-1.6%

Change from 52-week low

78.34%

Change from all-time high

-2.58%

Change from all-time low

11,410.45%

Change from open

1.49%

Day's gap

-0.48%

Dollar volume

ARS 384M

High price

ARS 38,460.00

Low price

ARS 37,220.00

Monthly RSI

75.95

Open price

ARS 37,640.00

Position in 52-week range

79.03%

Previous close

ARS 37,820.00

Price vs 150-day SMA

22.64%

Price vs 20-day SMA

6.54%

Price vs 200-day SMA

26.24%

Price vs 50-day SMA

10.26%

Relative volume

0.47

RSI

67.59

Sharpe ratio

1.54

Sharpe ratio (3Y)

1.31

Sharpe ratio (5Y)

1.76

Sortino ratio

2.67

Sortino ratio (3Y)

2.1

Sortino ratio (5Y)

2.87

Volume

10.1K

Weekly RSI

67.93

YTD price change

28.73%

YTD total return

29.1%

Metric	Value
Float	888.9M
Shares change (QoQ)	-0.25%
Shares change (YoY)	-0.62%
Shares held by insiders	0.17%
Shares held by institutions	89.37%
Short ratio	2.8 days

Metric

Value

Float

888.9M

Shares change (QoQ)

-0.25%

Shares change (YoY)

-0.62%

Shares held by insiders

0.17%

Shares held by institutions

89.37%

Short ratio

2.8 days

BCBA/LLY (BCBA/LLY)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/LLY

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/LLY indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/LLY

Frequently asked questions